Researchers found that certain immune cells, genes, and the drug metformin may help keep HIV dormant after treatment stops, ...

HealthDay News — Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer ...

Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at ...

Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of ...

Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3’s advancement ...

Researchers have engineered a synthetic Notch receptor system to directly label and profile cells interacting with developing T cells in the thymus. The study identified a broad network of immune and ...

A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma ...

A new nanomedicine strategy enhances irinotecan delivery in pancreatic tumors, reduces resistance, and boosts antitumor ...

U.S. Rep. Gabe Evans (R-CO) will face a Libertarian challenger this November in his run for reelection in Colorado’s 8th ...

While modern life includes many conveniences, humans are still incessantly exposed to a variety of metabolic stresses we have ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American ...